Ayala Pharmaceuticals Inc (fka ADXS)

[hovacre]

Appreciated. I hate trying to make predictions like that. For obvious reasons, I'm not feeling great about today, and I'm seriously considering cutting some of my line depending on how the stock market ends up reacting to the news (premarket is meaningless). Take some losses and move on from that.

With or without Axal, this is a pivotal few months for ADXS, though. So yes it's possible we'll stagnate and drift further down. But there are still events that are in the barrel that could lead to a significant change in market sentiment, particularly considering other companies in the same neoantigen space command valuations over 5 times higher than where ADXS sits right now.